Amendment No. 3 to Arena Pharmaceuticals, Inc. Amended and Restated Severance Benefit Plan

Contract Categories: Human Resources › Severance Agreements
Summary

This amendment adds Preston Klassen to Arena Pharmaceuticals, Inc.'s Severance Benefit Plan, granting him an 18-month severance period. The amendment is effective as of March 20, 2017, and is executed by the company's President and CEO. The agreement modifies the existing plan only to the extent of including this new participant and his specific severance terms.

Read More Arrow
EX-10.2 3 arna-ex102_8.htm EX-10.2 arna-ex102_8.htm

 

Exhibit 10.2

AMENDMENT NO. 3 TO

ARENA PHARMACEUTICALS, INC.

AMENDED AND RESTATED SEVERANCE BENEFIT PLAN

The Arena Pharmaceuticals, Inc., Amended and Restated Severance Benefit Plan, dated May 9, 2016, as amended (the “Plan”), is hereby further amended as of March 20, 2017, by this Amendment No. 3 as follows:

Preston Klassen is hereby added to Exhibit A of the Plan, with a Severance Period of 18 months.

To record the adoption of this Amendment No. 3, Arena Pharmaceuticals, Inc. has caused its duly authorized officer to execute the same this 20th day of March 2017.

 

 

Arena Pharmaceuticals, Inc.

 

/s/ Amit Munshi

Amit Munshi

President and Chief Executive Officer